Register
Healthed-White-on-Blue

Men's health

Revolutionising curative treatment for prostate cancer 3
Prof Sandra Turner
Podcasts iconPodcasts

Revolutionising curative treatment for prostate cancer

In today’s podcast, experts Prof Sandra Turner and A/Prof Lucinda Morris discuss radiation therapy as a key curative option for prostate cancer and its role in patient referrals.

Expert/s: Prof Sandra Turner, A/Prof Lucinda Morris
shutterstock_2366884339
Dr Beng Eu
Podcasts iconPodcasts

Anabolic steroids – Cases and practice tips: Prescribed and non-prescribed

In this podcast, Dr Beng Eu discusses anabolic steroids, consultation tips and investigations to support the monitoring of patients.

Expert/s: Dr Beng Eu
Man,With,Hands,Holding,His,Crotch,,He,Wants,To,Pee
Dr Michael Gillman
Podcasts iconPodcasts

Uncovering ED: Strategies, diagnostics, and new treatments

Dr Michael Gillman discusses current strategies to manage erectile dysfunction (ED), and what can be improved.

Expert/s: Dr Michael Gillman
Prostate,Cancer,Word,On,A,Paper,With,Stethoscope,And,Pills
Dr James MacKean
Podcasts iconPodcasts

Managing prostate cancer treatment update – Lecture

Dr James MacKean presents an overview of prostate cancer.

Expert/s: Dr James MacKean
shutterstock_1692958981
Dr Michael Lowy
Podcasts iconPodcasts

Medication-induced low libido and related problems in men

Dr Michael Lowy discusses the importance and detection of post-orgasmic illness syndrome, post-finasteride syndrome and post-SSRI syndrome.

Expert/s: Dr Michael Lowy
shutterstock_1393641158(1)
A/Prof Jeremy Grummet
Podcasts iconPodcasts

Management of elevated PSA

A/Prof Jeremy Grummet discusses the upcoming prostate-specific antigen (PSA) guidelines and benefits, and increasing the quality of patient care with current management options available.

Expert/s: A/Prof Jeremy Grummet
prostate cancer screening2
A/Prof Jeremy Grummet
Clinical Articles iconClinical Articles

Focal therapy for prostate cancer

Urological surgeon and focal therapy pioneer explains how this treatment may be used for intermediate-risk localised prostate cancer – and potential risks and pitfalls. Standard curative treatments of localised prostate cancer – radical prostatectomy or radiotherapy – treat the whole prostate gland...

Expert/s: A/Prof Jeremy Grummet
shutterstock_2155676941
A/Prof Jeremy Grummet
Podcasts iconPodcasts

Prostate cancer screening – Your questions answered

A/Prof Jeremy Grummet answers your most pressing questions regarding prostate cancer screening. These were compiled by GPs and health professionals around Australia.

Expert/s: A/Prof Jeremy Grummet
Asian,Elder,Man,Lifts,Dumbell,In,Gym
Emma Henshall
Clinical Articles iconClinical Articles

Testosterone for older men

You might think that more testosterone means greater vitality and wellbeing, but it’s more complicated than that says Professor Bu Yeap, consultant endocrinologist at Fiona Stanley Hospital, WA.

Expert/s: Emma Henshall
Kenneth Ho
A/Prof Kenneth Ho
Videos iconVideos

Testosterone scrotal cream for male hypogonadism

In this Product Explainer Endocrinologist A/Prof Kenneth Ho explains the role of testosterone scrotal cream for male hypogonadism confirmed by clinical assessment and measurement of serum testosterone (5 mins).

Expert/s: A/Prof Kenneth Ho
shutterstock_1404569909
Lynnette Hoffman
Clinical Articles iconClinical Articles

The future of PSA testing

Urologists and prostate cancer advocates say our prostate-specific antigen testing guidelines are out-of-date, and don’t account for advances that have reduced harms. The NHMRC and RACGP Red Book guidelines are undergoing review, and may ultimately promote more widespread use of PSA testing. But globally, epidemiologists remain concerned about overdiagnosis and overtreatment…

Expert/s: Lynnette Hoffman
Puzzle-head-Image-scaled
Healthed
Learning Modules iconLearning Modules

Dementia Prevention in Primary Care – A Mini Audit

This activity will focus on dementia prevention in primary care and will involve sending a link to a standardised questionnaire (CogDrisk) aimed at calculating a risk profile and identifying modifiable risk factors for dementia to all your patients between age 45-65, discussing the results with your patients and reporting on the outcomes in the report template provided.

Expert/s: Healthed

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform